At the recently opened FENS Forum 2026 in Barcelona - the Federation of European Neuroscience Societies' flagship congress and Europe's largest neuroscience meeting- a symposium on ectodomain shedding showcased how soluble synaptic proteins are emerging as both biomarkers and therapeutic candidates for disorders ranging from autism to schizophrenia.